Zelluna
Biotechnology Research
No
30 employees
- Employees
- 30
- Contacts
- 2
- Emails
- 2
Zelluna Overview
- Headquarters
- No
- Phone Number
- Available in AeroLeads
- Website
- zelluna.com
- Industry
- Biotechnology Research
- Employees
- 30
- Founded
- 2016
- Funding
- 4.6M
- Company Email
- Available in AeroLeads
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
About Zelluna
Zelluna Immunotherapy is a company pioneering the development of allogeneic T cell receptor (TCR) guided natural killer (NK) cell immunotherapies for the treatment of solid cancers. The company is developing a portfolio of tumor specific TCRs to guide NK cells with the aim to induce cancer responses that are safe, efficient and durable. For more info please visit www.zelluna.com
Zelluna Contact Details
- People in AeroLeads
- 4
- With contact data
- 2
- Email contacts
- 2
- 50.0% coverage
Zelluna Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| May Sabry | Directing Global Precision Medicine |
View
|
|
| Charlotte Berg-Svendsen | CEO at Cruda as / Cleantech & Life | Oslo, Norway |
Email
|
| Sylvie Pollmann | Sr. Group Leader Preclinical Research |
View
|
|
| Anders Holm | COO & Head of Business Development | Oslo, Norway |
Email
|
Employees by Management Level
Individual contributor
4 profiles
Senior / Lead
3 profiles
Executive
2 profiles
Department Contact Coverage
| Department | Contacts | Phone | |
|---|---|---|---|
| General | 2 | 2 | 0 |
Zelluna Tech Stack
Data / AI
4 profiles
Compare Similar Companies to Zelluna
Nykode Therapeutics
Biotechnology Research
T-knife Therapeutics
Biotechnology Research
Oncoinvent ASA
Biotechnology Research
Glycostem Therapeutics
Biotechnology
Lytix Biopharma
Biotechnology
BerGenBio ASA
Biotechnology Research
Circio Holding ASA
Biotechnology Research
ONK Therapeutics
Biotechnology Research
Pan Cancer T
Biotechnology Research
Ultimovacs ASA
Biotechnology